Igenesis
PrivateLast Round
Series B
Extension
Aug 26, 2021
Total Funding Raised
$85.4M
Company Overview
Igenesis is a biotechnology company that develops and manufactures automated PCR analysis platforms, medical diagnostic tools, and nucleic acid extraction kits for healthcare and forensic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Igenesis Comparables
Compare Igenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ustar Biotechnologies (Hangzhou) Ltd. | 86% | |
| Coyote Bioscience Co., Ltd. | 84% | |
| Daan Gene Co., Ltd. | 76% | |
Igenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 26, 2021 | ||||
| Series B | Jun 15, 2021 |
Igenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huimei Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 627% MoM, reaching 5.7K.
Igenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Igenesis's valuation, stock price, and market status.